The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 11, 2014
Filed:
Dec. 03, 2010
Stephen David Cosgrove, Macclesfield, GB;
Matthew Jonathan Jones, Södertälje, SE;
Anna Polyakova-akkus, West Lafayette, IN (US);
Valeriya Nikolayevna Smolenskaya, West Lafayette, IN (US);
Brenton Skylar Wolfe, West Lafayette, IN (US);
Stephen David Cosgrove, Macclesfield, GB;
Matthew Jonathan Jones, Södertälje, SE;
Anna Polyakova-Akkus, West Lafayette, IN (US);
Valeriya Nikolayevna Smolenskaya, West Lafayette, IN (US);
Brenton Skylar Wolfe, West Lafayette, IN (US);
Astrazeneca AB, Sodertalje, SE;
Abstract
The present invention relates to novel co-crystal forms of the compound of formula (I); wherein the co-former molecule is selected from glycolic acid, salicylic acid, decanoic (capric) acid, gentisic acid (2,5-dihydroxybenzoic acid), glutaric acid, vanillic acid (4-hydroxy-3-methoxybenzoic acid), succinic acid, malonic acid or maltol (3-hydroxy-2-methyl-4-pyrone); and to processes for their preparation, to pharmaceutical compositions containing such co-crystals, to the use of such co-crystals in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseases in the human or animal body by administering a therapeutically effective amount of a co-crystal of the compound of formula (I).